WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries? (Q44642720)

5 December 2017

WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries? (English)

1 reference

5 December 2017

11

1 reference

5 December 2017

Cécile Jeanpierre

16

0 references

Corinne Antignac

object named as

Corinne Antignac

15

0 references

author name string

Marie Corbin

1

1 reference

5 December 2017

Aurélien de Reyniès

2

1 reference

5 December 2017

David S Rickman

3

1 reference

5 December 2017

Dominique Berrebi

4

1 reference

5 December 2017

Liliane Boccon-Gibod

5

1 reference

5 December 2017

Sarah Cohen-Gogo

6

1 reference

5 December 2017

Monique Fabre

7

1 reference

5 December 2017

Francis Jaubert

8

1 reference

5 December 2017

Marine Faussillon

9

1 reference

5 December 2017

Funda Yilmaz

10

1 reference

5 December 2017

Judith Landman-Parker

12

1 reference

5 December 2017

Catherine Patte

13

1 reference

5 December 2017

Gudrun Schleiermacher

14

1 reference

5 December 2017

1 September 2009

1 reference

Genes, Chromosomes and Cancer

5 December 2017

1 reference

5 December 2017

48

1 reference

5 December 2017

816-827

1 reference

5 December 2017

9

1 reference

CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors

5 December 2017

1 reference

Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations

21 January 2018

1 reference

7 January 2021

Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43

1 reference

7 January 2021

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

1 reference

7 January 2021

Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells

1 reference

7 January 2021

Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function

1 reference

7 January 2021

Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay

1 reference

7 January 2021

Insights into the physiological role of WT1 from studies of genetically modified mice

1 reference

7 January 2021

Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development

1 reference

7 January 2021

The history of cancer epigenetics

1 reference

7 January 2021

Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.

1 reference

7 January 2021

Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies

1 reference

7 January 2021

Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes

1 reference

7 January 2021

Canonical WNT signalling determines lineage specificity in Wilms tumour

1 reference

7 January 2021

Infrequent mutation of theWT1 gene in 77 Wilms' tumors

1 reference

7 January 2021

A global test for groups of genes: testing association with a clinical outcome

1 reference

7 January 2021

Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling

1 reference

7 January 2021

WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells.

1 reference

7 January 2021

Analysis of array CGH data: from signal ratio to gain and loss of DNA regions

1 reference

7 January 2021

Canonical WNT signaling during kidney development

1 reference

7 January 2021

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

1 reference

7 January 2021

Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database

1 reference

7 January 2021

Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer

1 reference

7 January 2021

Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex

1 reference

7 January 2021

Beta-catenin directly regulates Islet1 expression in cardiovascular progenitors and is required for multiple aspects of cardiogenesis

1 reference

7 January 2021

A clinical overview of WT1 gene mutations

1 reference

7 January 2021

Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression

1 reference

7 January 2021

Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors

1 reference

7 January 2021

Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning

1 reference

7 January 2021

Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling

1 reference

7 January 2021

Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour

1 reference

7 January 2021

Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro.

1 reference

7 January 2021

The twist gene is a common target of retroviral integration and transcriptional deregulation in experimental nephroblastoma

1 reference

7 January 2021

Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors

1 reference

7 January 2021

An X chromosome gene, WTX, is commonly inactivated in Wilms tumor

1 reference

7 January 2021

Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor

1 reference

7 January 2021

Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors

1 reference

7 January 2021

Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors

1 reference

7 January 2021

WNT/beta-catenin signaling in nephron progenitors and their epithelial progeny.

1 reference

7 January 2021

Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation.

1 reference

7 January 2021

Regulation of casein kinase I epsilon activity by Wnt signaling

1 reference

7 January 2021

Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway

1 reference

7 January 2021

Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt.

1 reference

7 January 2021

SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions

1 reference

7 January 2021

FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma

1 reference

7 January 2021

Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation

1 reference

7 January 2021

Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells

1 reference

7 January 2021

Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.

1 reference

7 January 2021

Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer

1 reference

7 January 2021

Target genes of the WNT/beta-catenin pathway in Wilms tumors

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20686

1 reference

5 December 2017

1 reference